INTRODUCTION: Reductions in fibrinolytic potential occur with both aging and physical inactivity and are associated with an increased cardiovascular disease risk. Plasmin, the enzyme responsible for the enzymatic degradation of fibrin clots, is activated by tissue plasminogen activator (tPA), while plasminogen activator inhibitor-1 (PAI-1) inhibits its activation. Currently, fibrinolysis research focuses almost exclusively on changes within the plasma. However, tPA and PAI-1 are expressed by human skeletal muscle (SM). Currently, no studies have focused on changes in SM fibrinolytic activity with regard to aging and aerobic fitness. PURPOSE: The purpose of this study was to cross-sectionally evaluate effects of age and aerobic fitness on tPA and PAI-1 expressions and activity in SM. METHODS: Twenty-six male subjects were categorized into the following groups: (1) young aerobically trained (n = 8); (2) older aerobically trained (n = 6); (3) young aerobically untrained (n = 7); and (4) older aerobically untrained (n = 5). Muscle biopsies were obtained from each subject. SM tPA activity was assessed using gel zymography and SM tPA and PAI-1 expressions were assessed using RT-PCR. RESULTS: Trained subjects had higher SM tPA activity compared to untrained (25.3 ± 2.4 × 10(3) vs. 21.5 ± 5.6 × 10(3) pixels, respectively; p = 0.03) with no effect observed for age. VO2 max and SM tPA activity were also significantly correlated (r = 0.42; p < 0.04). SM tPA expression was higher in older participants, but no effect of fitness level was observed. No differences were observed for PAI-1 expression in SM. CONCLUSIONS: Higher levels of aerobic fitness are associated with increased fibrinolytic activity in SM.
INTRODUCTION: Reductions in fibrinolytic potential occur with both aging and physical inactivity and are associated with an increased cardiovascular disease risk. Plasmin, the enzyme responsible for the enzymatic degradation of fibrin clots, is activated by tissue plasminogen activator (tPA), while plasminogen activator inhibitor-1 (PAI-1) inhibits its activation. Currently, fibrinolysis research focuses almost exclusively on changes within the plasma. However, tPA and PAI-1 are expressed by human skeletal muscle (SM). Currently, no studies have focused on changes in SM fibrinolytic activity with regard to aging and aerobic fitness. PURPOSE: The purpose of this study was to cross-sectionally evaluate effects of age and aerobic fitness on tPA and PAI-1 expressions and activity in SM. METHODS: Twenty-six male subjects were categorized into the following groups: (1) young aerobically trained (n = 8); (2) older aerobically trained (n = 6); (3) young aerobically untrained (n = 7); and (4) older aerobically untrained (n = 5). Muscle biopsies were obtained from each subject. SM tPA activity was assessed using gel zymography and SM tPA and PAI-1 expressions were assessed using RT-PCR. RESULTS: Trained subjects had higher SM tPA activity compared to untrained (25.3 ± 2.4 × 10(3) vs. 21.5 ± 5.6 × 10(3) pixels, respectively; p = 0.03) with no effect observed for age. VO2 max and SM tPA activity were also significantly correlated (r = 0.42; p < 0.04). SM tPA expression was higher in older participants, but no effect of fitness level was observed. No differences were observed for PAI-1 expression in SM. CONCLUSIONS: Higher levels of aerobic fitness are associated with increased fibrinolytic activity in SM.
Authors: K Winther; W Hillegass; G H Tofler; A Jimenez; D A Brezinski; A I Schafer; J Loscalzo; G H Williams; J E Muller Journal: Am J Cardiol Date: 1992-10-15 Impact factor: 2.778
Authors: Denise Huber; Elisabeth M Cramer; Jocelyne E Kaufmann; Paolo Meda; Jean-Marc Massé; Egbert K O Kruithof; Ulrich M Vischer Journal: Blood Date: 2002-05-15 Impact factor: 22.113
Authors: Derek T Smith; Greta L Hoetzer; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza Journal: J Physiol Date: 2003-01-01 Impact factor: 5.182
Authors: Maria Gabriella Giganti; Ilaria Tresoldi; Roberto Sorge; Giovanni Melchiorri; Tamara Triossi; Laura Masuelli; Paolo Lido; Loredana Albonici; Calogero Foti; Andrea Modesti; Roberto Bei Journal: Oncol Lett Date: 2016-07-20 Impact factor: 2.967
Authors: Timothy P Gavin; Raymond M Kraus; John A Carrithers; Joseph P Garry; Robert C Hickner Journal: J Gerontol A Biol Sci Med Sci Date: 2014-09-02 Impact factor: 6.053
Authors: Jonathan G Stine; Ian R Schreibman; Alison J Faust; Jessica Dahmus; Benjamin Stern; Christopher Soriano; Gloriany Rivas; Breianna Hummer; Scot R Kimball; Nate R Geyer; Vernon M Chinchilli; Rohit Loomba; Kathryn Schmitz; Christopher Sciamanna Journal: Hepatology Date: 2022-01-22 Impact factor: 17.298
Authors: Fasih Ahmad Rahman; Sarah Anne Angus; Kyle Stokes; Phillip Karpowicz; Matthew Paul Krause Journal: Int J Mol Sci Date: 2020-06-27 Impact factor: 5.923
Authors: Simon Kwoon Ho Chow; Chung Yan Ho; Hiu Wun Wong; Yu Ning Chim; Ronald Man-Yeung Wong; Wing Hoi Cheung Journal: BMJ Open Date: 2020-12-15 Impact factor: 2.692
Authors: K Grabiec; A Majewska; Z Wicik; M Milewska; M Błaszczyk; K Grzelkowska-Kowalczyk Journal: Cell Biol Toxicol Date: 2016-04-25 Impact factor: 6.691